Overview

Long-term Safety and Efficacy Study of Octreotide Implant in Patients With Acromegaly

Status:
Terminated
Trial end date:
2012-06-01
Target enrollment:
Participant gender:
Summary
This is a long term study to evaluate the safety, tolerability and efficacy of an Octreotide Implant in patients that were previously treated with an Octreotide implant.
Phase:
Phase 3
Details
Lead Sponsor:
Endo Pharmaceuticals
Treatments:
Octreotide